This MedLibrary.org supplementary page on Fosaprepitant is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Fosaprepitant
|
|
| Systematic (IUPAC) name | |
| [3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl] ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo- 2H-1,2,4-triazol-1-yl]phosphonic acid | |
| Identifiers | |
| CAS number | 265121-04-8 (dimeglumine) |
| ATC code | A04 |
| PubChem | |
| Chemical data | |
| Formula | C23H22F7N4O6P |
| Mol. mass | 614.406 g/mol |
| Pharmacokinetic data | |
| Bioavailability | n/a |
| Protein binding | >95% (aprepitant) |
| Metabolism | To aprepitant |
| Half life | 9 to 13 hours (aprepitant) |
| Excretion | ? |
| Therapeutic considerations | |
| Licence data |
, |
| Pregnancy cat. |
B(US) |
| Legal status | |
| Routes | Intravenous |
Fosaprepitant (INN; trade names Emend for Injection, Ivemend) is an anti-emetic drug, administered intravenously. It is a prodrug of aprepitant.
It was developed by Merck & Co. and was approved by the United States Food and Drug Administration (FDA) on January 25, 2008 .[1] and by the European Medicines Agency (EMA) on January 11 of the same year.[2]
References
- ^ "Drugs.com, FDA Approves Emend (fosaprepitant dimeglumine) for Injection, Merck's New Intravenous Therapy, for Use in Combination with Other Antiemetics for Prevention of Nausea and Vomiting Caused by Chemotherapy". Retrieved on 2008-03-15.
- ^ "European Public Assessment Report for Ivemend (from the EMEA website)". Retrieved on 2008-03-15.
|
|||||||||||||||||||||||||||||
|
||||||||||||||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Wikipedia content modification information:
- This page was last modified on 28 May 2008, at 19:52.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Fosaprepitant".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.